title: Surreptitious drug use by patients in a panic disorder study.
abstract: In a double-blind, placebo-controlled trial comparing alprazolam and imipramine for panic disorder, serum analysis revealed that a substantial proportion of the patients took explicitly prohibited anxiolytic medication. Excluding these patients changed the results.
authors.affiliation: Department of Psychiatry, Stanford University Medical Center, Calif.
authors.forename: D B
authors.initials: DB
authors.lastname: Clark
authors.forename: C B
authors.initials: CB
authors.lastname: Taylor
authors.forename: W T
authors.initials: WT
authors.lastname: Roth
authors.forename: C
authors.initials: C
authors.lastname: Hayward
authors.forename: A
authors.initials: A
authors.lastname: Ehlers
authors.forename: J
authors.initials: J
authors.lastname: Margraf
authors.forename: W S
authors.initials: WS
authors.lastname: Agras
mesh_terms: D000328:Adult; D000525:Alprazolam / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000008:administration & dosage*; D001008:Anxiety Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000592:standards; D004311:Double-Blind Method; D005239:Fear; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D010043:Outcome and Process Assessment, Health Care; D010200:Panic; D010349:Patient Compliance; D010919:Placebos; D012651:Self Medication
chemical_list: D014151:Anti-Anxiety Agents; D010919:Placebos; D007099:Imipramine; D000525:Alprazolam